TA
Tamarack Advisers Portfolio holdings
AUM
$2.12M
This Quarter Return
+18.34%
1 Year Return
-56.28%
3 Year Return
-45.76%
5 Year Return
+44.93%
10 Year Return
–
AUM
$261M
AUM Growth
+$261M
(-8.6%)
Cap. Flow
-$378M
Cap. Flow
% of AUM
-144.92%
Top 10 Holdings %
Top 10 Hldgs %
67.6%
Holding
30
New
10
Increased
1
Reduced
16
Closed
1
Top Buys
| 1 |
Steris
STE
|
$12.7M |
| 2 |
Hologic
HOLX
|
$11.6M |
| 3 |
Pacira BioSciences
PCRX
|
$6.41M |
| 4 |
NVRO
NEVRO CORP.
NVRO
|
$6.06M |
| 5 |
SGNT
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
|
$3.89M |
Top Sells
| 1 |
PDCO
Patterson Companies, Inc.
PDCO
|
$327M |
| 2 |
Quest Diagnostics
DGX
|
$14.8M |
| 3 |
ELGX
Endologix Inc
ELGX
|
$11.1M |
| 4 |
Alkermes
ALKS
|
$10.9M |
| 5 |
NXTM
NxStage Medical Inc.
NXTM
|
$10.8M |
Sector Composition
| 1 | Healthcare | 75.74% |
| 2 | Technology | 7.03% |
| 3 | Communication Services | 0.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ELGX
1
DELISTED
Endologix Inc
ELGX
| $36.3M | 13.91% | 2,910,000 -890,000 | -23% | -$11.1M |
|
|
NXTM
2
DELISTED
NxStage Medical Inc.
NXTM
| $26M | 9.98% | 1,200,000 -500,000 | -29% | -$10.8M |
|
|
IMPR
3
DELISTED
IMPRIVATA, INC COM
IMPR
| $18.3M | 7.03% | 1,309,800 -400,200 | -23% | -$5.6M |
|
|
ARIA
4
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $15.5M | 5.95% | 2,100,000 +500,000 | +31% | +$3.7M |
|
|
5
Quest Diagnostics
DGX
$20.3B
| $14.9M | 5.73% | 183,457 -181,543 | -50% | -$14.8M |
|
6
Medtronic
MDT
$119B
| $14.7M | 5.62% | 169,000 -81,000 | -32% | -$7.03M |
|
|
SPNC
7
DELISTED
Spectranetics Corp
SPNC
| $13.4M | 5.13% | 714,200 -385,800 | -35% | -$7.22M |
|
|
MDRX
8
DELISTED
Veradigm Inc. Common Stock
MDRX
| $12.8M | 4.92% | 1,010,000 -640,000 | -39% | -$8.13M |
|
|
9
Steris
STE
$24.1B
| $12.7M | 4.88% | +185,000 | New | +$12.7M |
|
|
10
Hologic
HOLX
$14.9B
| $11.6M | 4.45% | +335,000 | New | +$11.6M |
|
|
LMNX
11
DELISTED
Luminex Corp
LMNX
| $10.6M | 4.08% | 526,000 -224,000 | -30% | -$4.53M |
|
|
12
Alkermes
ALKS
$4.78B
| $10.1M | 3.86% | 233,000 -252,000 | -52% | -$10.9M |
|
13
Bio-Rad Laboratories Class A
BIO
$8.06B
| $10M | 3.84% | 70,000 -30,000 | -30% | -$4.29M |
|
14
Labcorp
LH
$23.1B
| $9.77M | 3.75% | 75,000 -40,000 | -35% | -$5.21M |
|
|
15
Pacira BioSciences
PCRX
$1.2B
| $6.41M | 2.46% | +190,000 | New | +$6.41M |
|
|
NVRO
16
DELISTED
NEVRO CORP.
NVRO
| $6.06M | 2.33% | +82,200 | New | +$6.06M |
|
17
DexCom
DXCM
$29.5B
| $5.16M | 1.98% | 65,000 -6,000 | -8% | -$476K |
|
18
AtriCure
ATRC
$1.84B
| $4.75M | 1.82% | 336,000 -189,000 | -36% | -$2.67M |
|
|
AMRN
19
Amarin Corp
AMRN
$311M
| $3.89M | 1.49% | 1,800,000 -1,300,000 | -42% | -$2.81M |
|
|
SGNT
20
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $3.89M | 1.49% | +259,336 | New | +$3.89M |
|
|
CORI
21
DELISTED
Corium International, Inc.
CORI
| $3.73M | 1.43% | 1,075,000 -310,000 | -22% | -$1.08M |
|
|
PDCO
22
DELISTED
Patterson Companies, Inc.
PDCO
| $2.85M | 1.09% | 4,750 -545,250 | -99% | -$327M |
|
|
RLYP
23
DELISTED
RELYPSA INC COM
RLYP
| $1.75M | 0.67% | +94,475 | New | +$1.75M |
|
|
STRM
24
DELISTED
Streamline Health Solutions
STRM
| $1.37M | 0.52% | 1,138,000 | – | – |
|
25
Collegium Pharmaceutical
COLL
$1.22B
| $1.13M | 0.43% | +94,908 | New | +$1.13M |
|